Novo Nordisk Continues to Limit Supply of Blockbuster Weight-Loss Drug
November 02 2023 - 3:11AM
Dow Jones News
By Dominic Chopping
Novo Nordisk is gradually expanding supply capacity for its
blockbuster weight-loss drug, but said it will continue to limit
supply of lower-strength doses of the Wegovy medicine in the U.S.
as it seeks to safeguard supplies.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
November 02, 2023 02:56 ET (06:56 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2024 to May 2024
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From May 2023 to May 2024
